Form 4: Director Sells ALZN Shares for Tax Loss Realization
Insider Transaction Report
Alzamend Neuro Director Milton C. Ault III sold 1,851 shares of common stock to realize tax losses, maintaining significant indirect ownership.
Summary
- Milton C. Ault III, a Director and 10% Owner of Alzamend Neuro, Inc. (ALZN), reported a transaction involving the sale of common stock.
- On December 23, 2025, Mr. Ault disposed of 1,851 shares of Alzamend Neuro common stock.
- The shares were sold at a price of $2.0665 per share.
- The stated purpose for this sale was for realizing tax losses.
- Following this transaction, Mr. Ault directly owns 0 shares of common stock.
- He continues to indirectly beneficially own 8,260 shares through Ault Lending, LLC, 11,068 shares through Ault Life Sciences, Inc., and 61 shares through Ault Life Sciences Fund, LLC.
Sentiment
Score: 3
Explanation: A director's sale of shares, especially when explicitly for 'realizing tax losses,' can be perceived negatively by the market as it suggests the shares have declined in value since acquisition and/or the insider is reducing exposure. While the amount is relatively small compared to total indirect holdings, the reason for sale is not a positive catalyst.
Negatives
- A director's sale of shares, even for tax loss purposes, can be perceived negatively by the market as it may signal a lack of confidence or a need for liquidity.
- The explicit mention of 'realizing tax losses' implies that the shares were sold at a loss relative to their acquisition cost, which could reflect poorly on the stock's performance.
Risks
- Potential negative market perception and investor sentiment due to a director's sale of shares, especially when the reason is explicitly stated as 'realizing tax losses'.
- The sale price of $2.0665 per share may indicate a decline in the company's stock value, contributing to the opportunity for tax loss realization.
Future Outlook
NA
Management Comments
- Such shares were sold at the direction of the reporting person, for purposes of realizing tax losses.
Industry Context
NA
Stakeholder Impact
- Shareholders: May interpret the director's sale, particularly for tax losses, as a negative signal regarding the company's short-term prospects or share price stability, potentially leading to increased selling pressure or reduced investor confidence.
Key Dates
| Date | Description |
|---|---|
| 12/23/2025 | Date of transaction (sale of common stock by Milton C. Ault III) |
| 12/30/2025 | Signature date of the reporting person on the Form 4 |
Recommendation
holdWhile a director's sale for tax loss realization is a personal financial decision, it can be interpreted by the market as a negative signal regarding the stock's performance or future prospects. However, the amount sold is relatively small compared to the total indirect holdings, and the stated reason is specific to tax planning rather than a fundamental change in company outlook. Investors should monitor future insider activity and company performance rather than making a strong buy or sell decision based solely on this single transaction.
Keywords
Alzamend Neuro, ALZN, Milton C. Ault III, Form 4, Insider Trading, Director Sale, Tax Loss Realization, Beneficial Ownership, SEC Filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.